首页 > 最新文献

Quality & Safety in Health Care最新文献

英文 中文
Quality and Safety in the Literature: May 2022 文献中的质量与安全:2022年5月
Pub Date : 2022-04-12 DOI: 10.1136/bmjqs-2022-014848
Albert G. Emery, N. Houchens, Ashwin Gupta
© Author(s) (or their employer(s)) 2022. No commercial reuse. See rights and permissions. Published by BMJ. COMPARATIVE EFFECTIVENESS OF AN AUTOMATED TEXT MESSAGING SERVICE FOR MONITORING COVID-19 AT HOME Ann Intern Med, 16 November 2021 As cases of SARSCoV2 infection (COVID19) have risen dramatically over the course of the pandemic, global interest in utilisation of telemedicine services has increased. 2 In an effort to avoid exposure to infected persons in healthcare settings, the total number of virtual health encounters has risen sharply in both primary care and subspecialty clinics. 4 Even prior to the onset of the pandemic, telemedicine services were used in a myriad of specialties, ranging from cardiothoracic surgery to psychiatry to palliative care as a means of monitoring symptoms and collecting patient data to detect and address early patient deterioration and prevent excess morbidity and mortality. Early in the pandemic, clinicians and researchers quickly noted the opportunities for telemedicine to prevent such morbidity and mortality specifically related to COVID19. 9 An application called COVID Watch, developed by researchers at the University of Pennsylvania Health System (Penn Medicine), is a home monitoring programme for outpatients diagnosed with COVID19. COVID Watch sends twicedaily automated text messages to patients, inquiring about worsening symptoms and increased shortness of breath. In the event of worsening shortness of breath, the patient is contacted by a clinician via telephone within 1 hour for further evaluation and consideration of emergency department (ED) escalation. To understand the effectiveness of the COVID Watch programme, Delgado and colleagues performed a retrospective cohort study, analysing a population of patients within Penn Medicine. Included patients were adults aged 18 years or older who tested positive for COVID19 in the outpatient setting between 23 March and 30 November 2020. Excluded were people enrolled in home health or hospice services, those residing at longterm care facilities, those with active ‘do not resuscitate’ orders and those tested for COVID19 in areas where COVID Healthcare quality and safety span multiple topics across the spectrum of academic and clinical disciplines. Keeping abreast of the rapidly growing body of work can be challenging. In this series, we provide succinct summaries of selected relevant studies published in the last several months. Some articles will focus on a particular theme, whereas others will highlight unique publications from highimpact medical journals.
©作者(或其雇主)2022。无商业再利用。请参阅权限和权限。BMJ出版。2021年11月16日,在HOME Ann Intern Med监测新冠肺炎的自动短信服务的比较效果随着SARSCoV2感染(COVID19)病例在大流行期间急剧上升,全球对远程医疗服务利用的兴趣也在增加。2为了避免在医疗环境中接触到感染者,初级保健和专科诊所的虚拟健康接触总数都急剧增加。4甚至在疫情爆发之前,远程医疗服务就被用于许多专业,从心胸外科到精神病学再到姑息治疗,作为监测症状和收集患者数据的一种手段,以检测和解决早期患者恶化问题,防止过度发病率和死亡率。在疫情早期,临床医生和研究人员很快注意到远程医疗有机会预防这种与新冠肺炎特别相关的发病率和死亡率19。9宾夕法尼亚大学卫生系统(宾夕法尼亚医学院)的研究人员开发了一款名为“新冠肺炎观察”的应用程序,它是一项针对确诊为新冠肺炎的门诊患者的家庭监测计划19。COVID Watch每两次自动向患者发送短信,询问症状恶化和呼吸急促加剧的情况。如果呼吸急促恶化,临床医生会在1小时内通过电话联系患者,以进行进一步评估并考虑急诊科(ED)的升级。为了了解新冠肺炎观察计划的有效性,Delgado及其同事进行了一项回顾性队列研究,分析了宾夕法尼亚医学院的患者群体。纳入的患者是2020年3月23日至11月30日期间在门诊环境中新冠肺炎检测呈阳性的18岁或以上的成年人19。排除在外的有参加家庭健康或临终关怀服务的人、居住在长期护理机构的人、有积极“不复苏”命令的人,以及在新冠肺炎医疗质量和安全涉及学术和临床学科多个主题的地区接受新冠肺炎检测的人19。跟上快速增长的工作量可能具有挑战性。在本系列中,我们简要总结了过去几个月发表的一些相关研究。一些文章将聚焦于一个特定的主题,而另一些文章则强调来自高影响力医学期刊的独特出版物。
{"title":"Quality and Safety in the Literature: May 2022","authors":"Albert G. Emery, N. Houchens, Ashwin Gupta","doi":"10.1136/bmjqs-2022-014848","DOIUrl":"https://doi.org/10.1136/bmjqs-2022-014848","url":null,"abstract":"© Author(s) (or their employer(s)) 2022. No commercial reuse. See rights and permissions. Published by BMJ. COMPARATIVE EFFECTIVENESS OF AN AUTOMATED TEXT MESSAGING SERVICE FOR MONITORING COVID-19 AT HOME Ann Intern Med, 16 November 2021 As cases of SARSCoV2 infection (COVID19) have risen dramatically over the course of the pandemic, global interest in utilisation of telemedicine services has increased. 2 In an effort to avoid exposure to infected persons in healthcare settings, the total number of virtual health encounters has risen sharply in both primary care and subspecialty clinics. 4 Even prior to the onset of the pandemic, telemedicine services were used in a myriad of specialties, ranging from cardiothoracic surgery to psychiatry to palliative care as a means of monitoring symptoms and collecting patient data to detect and address early patient deterioration and prevent excess morbidity and mortality. Early in the pandemic, clinicians and researchers quickly noted the opportunities for telemedicine to prevent such morbidity and mortality specifically related to COVID19. 9 An application called COVID Watch, developed by researchers at the University of Pennsylvania Health System (Penn Medicine), is a home monitoring programme for outpatients diagnosed with COVID19. COVID Watch sends twicedaily automated text messages to patients, inquiring about worsening symptoms and increased shortness of breath. In the event of worsening shortness of breath, the patient is contacted by a clinician via telephone within 1 hour for further evaluation and consideration of emergency department (ED) escalation. To understand the effectiveness of the COVID Watch programme, Delgado and colleagues performed a retrospective cohort study, analysing a population of patients within Penn Medicine. Included patients were adults aged 18 years or older who tested positive for COVID19 in the outpatient setting between 23 March and 30 November 2020. Excluded were people enrolled in home health or hospice services, those residing at longterm care facilities, those with active ‘do not resuscitate’ orders and those tested for COVID19 in areas where COVID Healthcare quality and safety span multiple topics across the spectrum of academic and clinical disciplines. Keeping abreast of the rapidly growing body of work can be challenging. In this series, we provide succinct summaries of selected relevant studies published in the last several months. Some articles will focus on a particular theme, whereas others will highlight unique publications from highimpact medical journals.","PeriodicalId":49653,"journal":{"name":"Quality & Safety in Health Care","volume":"31 1","pages":"409 - 414"},"PeriodicalIF":0.0,"publicationDate":"2022-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45509146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of the surgical safety checklist on provider and patient outcomes: a systematic review 手术安全检查表对提供者和患者结果的影响:系统回顾
Pub Date : 2022-04-07 DOI: 10.1136/bmjqs-2021-014361
B. Armstrong, I. A. Dutescu, Lori Nemoy, Ekta Bhavsar, Diana N. Carter, Kimberley-Dale Ng, S. Boet, P. Trbovich, V. Palter
Background Despite being implemented for over a decade, literature describing how the surgical safety checklist (SSC) is completed by operating room (OR) teams and how this relates to its effectiveness is scarce. This systematic review aimed to: (1) quantify how many studies reported SSC completion versus described how the SSC was completed; (2) evaluate the impact of the SSC on provider outcomes (Communication, case Understanding, Safety Culture, CUSC), patient outcomes (complications, mortality rates) and moderators of these relationships. Methods A systematic literature search was conducted using Medline, CINAHL, Embase, PsycINFO, PubMed, Scopus and Web of Science on 10 January 2020. We included providers who treat human patients and completed any type of SSC in any OR or simulation centre. Statistical directional findings were extracted for provider and patient outcomes and key factors (eg, attentiveness) were used to determine moderating effects. Results 300 studies were included in the analysis comprising over 7 302 674 operations and 2 480 748 providers and patients. Thirty-eight per cent of studies provided at least some description of how the SSC was completed. Of the studies that described SSC completion, a clearer positive relationship was observed concerning the SSC’s influence on provider outcomes (CUSC) compared with patient outcomes (complications and mortality), as well as related moderators. Conclusion There is a scarcity of research that examines how the SSC is completed and how this influences safety outcomes. Examining how a checklist is completed is critical for understanding why the checklist is successful in some instances and not others.
背景尽管实施了十多年,但描述手术室(OR)团队如何完成手术安全检查表(SSC)以及这与其有效性的关系的文献很少。该系统综述旨在:(1)量化有多少研究报告了SSC完成,而描述了SSC是如何完成的;(2) 评估SSC对提供者结果(沟通、病例理解、安全文化、CUSC)、患者结果(并发症、死亡率)和这些关系的调节因素的影响。方法于2020年1月10日使用Medline、CINAHL、Embase、PsycINFO、PubMed、Scopus和Web of Science进行系统的文献检索。我们包括在任何手术室或模拟中心治疗人类患者并完成任何类型SSC的提供者。提取提供者和患者结果的统计方向性结果,并使用关键因素(如注意力)来确定调节效果。结果分析中包括300项研究,包括7项以上 302 674次操作和2次 480 748名提供者和患者。38%的研究至少对SSC是如何完成的提供了一些描述。在描述SSC完成情况的研究中,观察到SSC对提供者结果(CUSC)的影响与患者结果(并发症和死亡率)以及相关调节因子之间存在更明确的正相关关系。结论很少有研究来检查SSC是如何完成的,以及这如何影响安全结果。检查检查表是如何完成的,对于理解为什么检查表在某些情况下是成功的而在其他情况下不是成功的至关重要。
{"title":"Effect of the surgical safety checklist on provider and patient outcomes: a systematic review","authors":"B. Armstrong, I. A. Dutescu, Lori Nemoy, Ekta Bhavsar, Diana N. Carter, Kimberley-Dale Ng, S. Boet, P. Trbovich, V. Palter","doi":"10.1136/bmjqs-2021-014361","DOIUrl":"https://doi.org/10.1136/bmjqs-2021-014361","url":null,"abstract":"Background Despite being implemented for over a decade, literature describing how the surgical safety checklist (SSC) is completed by operating room (OR) teams and how this relates to its effectiveness is scarce. This systematic review aimed to: (1) quantify how many studies reported SSC completion versus described how the SSC was completed; (2) evaluate the impact of the SSC on provider outcomes (Communication, case Understanding, Safety Culture, CUSC), patient outcomes (complications, mortality rates) and moderators of these relationships. Methods A systematic literature search was conducted using Medline, CINAHL, Embase, PsycINFO, PubMed, Scopus and Web of Science on 10 January 2020. We included providers who treat human patients and completed any type of SSC in any OR or simulation centre. Statistical directional findings were extracted for provider and patient outcomes and key factors (eg, attentiveness) were used to determine moderating effects. Results 300 studies were included in the analysis comprising over 7 302 674 operations and 2 480 748 providers and patients. Thirty-eight per cent of studies provided at least some description of how the SSC was completed. Of the studies that described SSC completion, a clearer positive relationship was observed concerning the SSC’s influence on provider outcomes (CUSC) compared with patient outcomes (complications and mortality), as well as related moderators. Conclusion There is a scarcity of research that examines how the SSC is completed and how this influences safety outcomes. Examining how a checklist is completed is critical for understanding why the checklist is successful in some instances and not others.","PeriodicalId":49653,"journal":{"name":"Quality & Safety in Health Care","volume":"31 1","pages":"463 - 478"},"PeriodicalIF":0.0,"publicationDate":"2022-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49142092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Channelling the force of audit and feedback: averting the dark side 引导审计和反馈的力量:避免黑暗面
Pub Date : 2022-03-29 DOI: 10.1136/bmjqs-2021-014520
Eilidh M. Duncan, N. Ivers, J. Grimshaw
{"title":"Channelling the force of audit and feedback: averting the dark side","authors":"Eilidh M. Duncan, N. Ivers, J. Grimshaw","doi":"10.1136/bmjqs-2021-014520","DOIUrl":"https://doi.org/10.1136/bmjqs-2021-014520","url":null,"abstract":"","PeriodicalId":49653,"journal":{"name":"Quality & Safety in Health Care","volume":"31 1","pages":"695 - 697"},"PeriodicalIF":0.0,"publicationDate":"2022-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41999240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Experience of hospital-initiated medication changes in older people with multimorbidity: a multicentre mixed-methods study embedded in the OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM) trial 多病老年人医院启动药物改变的经验:一项多中心混合方法研究嵌入了优化治疗以防止多病老年人可避免的住院(OPERAM)试验
Pub Date : 2022-03-29 DOI: 10.1136/bmjqs-2021-014372
S. Thevelin, Catherine Pétein, Beatrice Metry, L. Adam, Anniek van Herksen, K. Murphy, W. Knol, D. O’Mahony, N. Rodondi, A. Spinewine, O. Dalleur
Background A patient-centred approach to medicines optimisation is considered essential. The OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM) trial evaluated the effectiveness of medication review with shared decision-making (SDM) in older people with multimorbidity. Beyond evaluating the clinical effectiveness, exploring the patient experience facilitates a better understanding of contextual factors and mechanisms affecting medication review effectiveness. Objective To explore experiences of hospital-initiated medication changes in older people with multimorbidity. Methods We conducted a multicentre mixed-methods study, embedded in the OPERAM trial, combining semi-structured interviews and the Beliefs about Medicines Questionnaire (BMQ) with a purposive sample of 48 patients (70–94 years) from four European countries. Interviews were analysed using the Framework approach. Trial implementation data on SDM were collected and the 9-item SDM questionnaire was conducted with 17 clinicians. Results Patients generally displayed positive attitudes towards medication review, yet emphasised the importance of long-term, trusting relationships such as with their general practitioners for medication review. Many patients reported a lack of information and communication about medication changes and predominantly experienced paternalistic decision-making. Patients’ beliefs that ‘doctors know best’, ‘blind trust’, having limited opportunities for questions, use of jargon terms by clinicians, ‘feeling too ill’, dismissive clinicians, etc highlight the powerlessness some patients felt during hospitalisation, all representing barriers to SDM. Conversely, involvement of companions, health literacy, empathetic and trusting patient-doctor relationships, facilitated SDM. Paradoxical to patients’ experiential accounts, clinicians reported high levels of SDM. The BMQ showed that most patients had high necessity and low concern beliefs about medicines. Beliefs about medicines, experiencing benefits or harms from medication changes, illness perception, trust and balancing advice between different healthcare professionals all affected acceptance of medication changes. Conclusion To meet patients’ needs, future medicines optimisation interventions should enhance information exchange, better prepare patients and clinicians for partnership in care and foster collaborative medication reviews across care settings.
以患者为中心的药物优化方法被认为是必不可少的。优化治疗预防多病老年人可避免住院(OPERAM)试验评估了共同决策的药物审查(SDM)在多病老年人中的有效性。除了评估临床效果,探索患者体验有助于更好地理解影响药物审查效果的背景因素和机制。目的探讨老年多病患者院源性用药改变的经验。方法:我们进行了一项多中心混合方法研究,嵌入在OPERAM试验中,结合半结构化访谈和药物信念问卷(BMQ),目的样本为来自四个欧洲国家的48例患者(70-94岁)。访谈采用框架方法进行分析。收集SDM的试验实施数据,对17名临床医生进行9项SDM问卷调查。结果患者普遍对药物审查持积极态度,但强调长期信任关系的重要性,如与全科医生进行药物审查。许多患者报告缺乏关于药物变化的信息和沟通,主要经历家长式决策。患者认为“医生最懂”、“盲目信任”、提问机会有限、临床医生使用术语、“感觉病得太重”、临床医生不屑一顾等等,这些都凸显了一些患者在住院期间感到的无力感,这些都是SDM的障碍。相反,同伴的参与、健康知识、同理心和信任的医患关系促进了可持续发展。与患者的经验描述相矛盾的是,临床医生报告了高水平的SDM。BMQ结果显示,大多数患者对药物的需求程度高,关注程度低。对药物的信念、药物变化带来的益处或危害、对疾病的感知、不同医疗保健专业人员之间的信任和平衡建议都会影响对药物变化的接受程度。结论为了满足患者的需求,未来的药物优化干预措施应加强信息交流,使患者和临床医生更好地为护理伙伴关系做好准备,并促进跨护理机构的协作性药物审查。
{"title":"Experience of hospital-initiated medication changes in older people with multimorbidity: a multicentre mixed-methods study embedded in the OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM) trial","authors":"S. Thevelin, Catherine Pétein, Beatrice Metry, L. Adam, Anniek van Herksen, K. Murphy, W. Knol, D. O’Mahony, N. Rodondi, A. Spinewine, O. Dalleur","doi":"10.1136/bmjqs-2021-014372","DOIUrl":"https://doi.org/10.1136/bmjqs-2021-014372","url":null,"abstract":"Background A patient-centred approach to medicines optimisation is considered essential. The OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM) trial evaluated the effectiveness of medication review with shared decision-making (SDM) in older people with multimorbidity. Beyond evaluating the clinical effectiveness, exploring the patient experience facilitates a better understanding of contextual factors and mechanisms affecting medication review effectiveness. Objective To explore experiences of hospital-initiated medication changes in older people with multimorbidity. Methods We conducted a multicentre mixed-methods study, embedded in the OPERAM trial, combining semi-structured interviews and the Beliefs about Medicines Questionnaire (BMQ) with a purposive sample of 48 patients (70–94 years) from four European countries. Interviews were analysed using the Framework approach. Trial implementation data on SDM were collected and the 9-item SDM questionnaire was conducted with 17 clinicians. Results Patients generally displayed positive attitudes towards medication review, yet emphasised the importance of long-term, trusting relationships such as with their general practitioners for medication review. Many patients reported a lack of information and communication about medication changes and predominantly experienced paternalistic decision-making. Patients’ beliefs that ‘doctors know best’, ‘blind trust’, having limited opportunities for questions, use of jargon terms by clinicians, ‘feeling too ill’, dismissive clinicians, etc highlight the powerlessness some patients felt during hospitalisation, all representing barriers to SDM. Conversely, involvement of companions, health literacy, empathetic and trusting patient-doctor relationships, facilitated SDM. Paradoxical to patients’ experiential accounts, clinicians reported high levels of SDM. The BMQ showed that most patients had high necessity and low concern beliefs about medicines. Beliefs about medicines, experiencing benefits or harms from medication changes, illness perception, trust and balancing advice between different healthcare professionals all affected acceptance of medication changes. Conclusion To meet patients’ needs, future medicines optimisation interventions should enhance information exchange, better prepare patients and clinicians for partnership in care and foster collaborative medication reviews across care settings.","PeriodicalId":49653,"journal":{"name":"Quality & Safety in Health Care","volume":"31 1","pages":"888 - 898"},"PeriodicalIF":0.0,"publicationDate":"2022-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42400970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
The problem with making Safety-II work in healthcare 使Safety-II在医疗保健领域发挥作用的问题
Pub Date : 2022-03-18 DOI: 10.1136/bmjqs-2021-014396
M. Verhagen, M. D. de Vos, M. Sujan, J. Hamming
© Author(s) (or their employer(s)) 2022. No commercial reuse. See rights and permissions. Published by BMJ. INTRODUCTION Patient safety is typically assessed by the frequency of adverse events or incidents, which means we seek to determine safety by its absence rather than its presence. The SafetyII perspective aspires to overcome this paradox by bringing into focus situations where safety is actually present, that is, in everyday work that usually goes well. Central to SafetyII is the notion that, in complex systems such as healthcare, safety is a consequence of collective efforts to adapt to dynamic conditions and uncertainty, rather than the natural state of a system where nothing untoward happens. This type of thinking has been met with significant interest and enthusiasm in healthcare, because it feeds increased appreciation for the fact that healthcare workers continuously ensure that most patients receive safe and highquality care in challenging circumstances. However, despite its appeal and potential, significant challenges remain for the fruitful interpretation and application of the SafetyII perspective in healthcare, which could give rise to misinterpretations, misuse and a missed opportunity for the potential enrichment of quality and safety practices in healthcare.
©作者(或其雇主)2022。禁止商业重用。请参阅权利和权限。英国医学杂志出版。患者安全通常是通过不良事件或事件的频率来评估的,这意味着我们试图通过其不存在而不是存在来确定安全性。SafetyII的观点希望通过关注安全实际存在的情况来克服这种矛盾,也就是说,在日常工作中通常进行得很顺利。safety ii的核心概念是,在医疗保健等复杂系统中,安全是集体努力适应动态条件和不确定性的结果,而不是没有任何不幸发生的系统的自然状态。这种类型的想法在医疗保健领域引起了极大的兴趣和热情,因为它使人们越来越认识到这样一个事实,即医疗保健工作者不断确保大多数患者在具有挑战性的环境中获得安全和高质量的护理。然而,尽管它具有吸引力和潜力,但在医疗保健中卓有成效地解释和应用SafetyII观点仍然面临重大挑战,这可能导致误解、误用和错过潜在的丰富医疗保健质量和安全实践的机会。
{"title":"The problem with making Safety-II work in healthcare","authors":"M. Verhagen, M. D. de Vos, M. Sujan, J. Hamming","doi":"10.1136/bmjqs-2021-014396","DOIUrl":"https://doi.org/10.1136/bmjqs-2021-014396","url":null,"abstract":"© Author(s) (or their employer(s)) 2022. No commercial reuse. See rights and permissions. Published by BMJ. INTRODUCTION Patient safety is typically assessed by the frequency of adverse events or incidents, which means we seek to determine safety by its absence rather than its presence. The SafetyII perspective aspires to overcome this paradox by bringing into focus situations where safety is actually present, that is, in everyday work that usually goes well. Central to SafetyII is the notion that, in complex systems such as healthcare, safety is a consequence of collective efforts to adapt to dynamic conditions and uncertainty, rather than the natural state of a system where nothing untoward happens. This type of thinking has been met with significant interest and enthusiasm in healthcare, because it feeds increased appreciation for the fact that healthcare workers continuously ensure that most patients receive safe and highquality care in challenging circumstances. However, despite its appeal and potential, significant challenges remain for the fruitful interpretation and application of the SafetyII perspective in healthcare, which could give rise to misinterpretations, misuse and a missed opportunity for the potential enrichment of quality and safety practices in healthcare.","PeriodicalId":49653,"journal":{"name":"Quality & Safety in Health Care","volume":"31 1","pages":"402 - 408"},"PeriodicalIF":0.0,"publicationDate":"2022-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46196892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 27
Speaking up in resource-constrained settings: how to secure safe surgical care in the moment and in the future? 在资源受限的环境下大声疾呼:如何在当下和未来确保安全的手术护理?
Pub Date : 2022-03-15 DOI: 10.1136/bmjqs-2021-014624
Graham P. Martin, N. Armstrong
{"title":"Speaking up in resource-constrained settings: how to secure safe surgical care in the moment and in the future?","authors":"Graham P. Martin, N. Armstrong","doi":"10.1136/bmjqs-2021-014624","DOIUrl":"https://doi.org/10.1136/bmjqs-2021-014624","url":null,"abstract":"","PeriodicalId":49653,"journal":{"name":"Quality & Safety in Health Care","volume":"31 1","pages":"631 - 633"},"PeriodicalIF":0.0,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43839312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Quality and Safety in the Literature: March 2022 文献中的质量与安全:2022年3月
Pub Date : 2022-03-01 DOI: 10.1136/bmjqs-2021-014678
I. Khurana, Ashwin Gupta, N. Houchens
{"title":"Quality and Safety in the Literature: March 2022","authors":"I. Khurana, Ashwin Gupta, N. Houchens","doi":"10.1136/bmjqs-2021-014678","DOIUrl":"https://doi.org/10.1136/bmjqs-2021-014678","url":null,"abstract":"","PeriodicalId":49653,"journal":{"name":"Quality & Safety in Health Care","volume":"31 1","pages":"238 - 242"},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48542757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduced rate of postpartum readmissions among homeless compared with non-homeless women in New York: a population-based study using serial, cross-sectional data 纽约无家可归妇女与非无家可归妇女相比产后再入院率降低:一项使用系列横断面数据的基于人群的研究
Pub Date : 2021-06-16 DOI: 10.1136/bmjqs-2020-012898
Rie Sakai-Bizmark, H. Kumamaru, Dennys Estevez, Sophia Neman, Lauren E. M. Bedel, Laurie A Mena, Emily H Marr, M. Ross
Objective To assess differences in rates of postpartum hospitalisations among homeless women compared with non-homeless women. Design Cross-sectional secondary analysis of readmissions and emergency department (ED) utilisation among postpartum women using hierarchical regression models adjusted for age, race/ethnicity, insurance type during delivery, delivery length of stay, maternal comorbidity index score, other pregnancy complications, neonatal complications, caesarean delivery, year fixed effect and a birth hospital random effect. Setting New York statewide inpatient and emergency department databases (2009–2014). Participants 82 820 and 1 026 965 postpartum homeless and non-homeless women, respectively. Main outcome measures Postpartum readmissions (primary outcome) and postpartum ED visits (secondary outcome) within 6 weeks after discharge date from delivery hospitalisation. Results Homeless women had lower rates of both postpartum readmissions (risk-adjusted rates: 1.4% vs 1.6%; adjusted OR (aOR) 0.87, 95% CI 0.75 to 1.00, p=0.048) and ED visits than non-homeless women (risk-adjusted rates: 8.1% vs 9.5%; aOR 0.83, 95% CI 0.77 to 0.90, p<0.001). A sensitivity analysis stratifying the non-homeless population by income quartile revealed significantly lower hospitalisation rates of homeless women compared with housed women in the lowest income quartile. These results were surprising due to the trend of postpartum hospitalisation rates increasing as income levels decreased. Conclusions Two factors likely led to lower rates of hospital readmissions among homeless women. First, barriers including lack of transportation, payment or childcare could have impeded access to postpartum inpatient and emergency care. Second, given New York State’s extensive safety net, discharge planning such as respite and sober living housing may have provided access to outpatient care and quality of life, preventing adverse health events. Additional research using outpatient data and patient perspectives is needed to recognise how the factors affect postpartum health among homeless women. These findings could aid in lowering readmissions of the housed postpartum population.
目的评估无家可归妇女与非无家可归妇女产后住院率的差异。设计产后妇女再次入院和急诊科(ED)利用率的横断面二次分析,使用分层回归模型,根据年龄、种族/民族、分娩期间的保险类型、分娩停留时间、产妇合并症指数评分、其他妊娠并发症、新生儿并发症、剖腹产,年份固定效应和出生医院随机效应。建立纽约州住院和急诊科数据库(2009-2014年)。参与者82 820和1 026 产后无家可归和非无家可归妇女分别为965人。主要转归指标产后再次入院(主要转归)和产后急诊就诊(次要转归) 出院后数周分娩住院。结果与非无家可归妇女相比,无家可归妇女的产后再入院率(风险调整率:1.4%对1.6%;调整后OR(aOR)0.87,95%CI 0.75至1.00,p=0.048)和急诊就诊率均较低(风险调整后率:8.1%对9.5%;aOR 0.83,95%) CI 0.77至0.90,p<0.001)。根据收入四分位数对非无家可归人群进行的敏感性分析显示,与收入最低四分位数的居住妇女相比,无家可归妇女的住院率显著较低。这些结果令人惊讶,因为随着收入水平的下降,产后住院率呈上升趋势。结论两个因素可能导致无家可归妇女再次入院率降低。首先,包括缺乏交通、付款或儿童保育在内的障碍可能会阻碍产后住院和急诊的获得。其次,考虑到纽约州广泛的安全网,出院计划,如休息和清醒生活住房,可能提供了门诊护理和生活质量,防止了不良健康事件。需要利用门诊数据和患者视角进行更多研究,以了解这些因素如何影响无家可归妇女的产后健康。这些发现可能有助于降低住院产后人群的再次入院率。
{"title":"Reduced rate of postpartum readmissions among homeless compared with non-homeless women in New York: a population-based study using serial, cross-sectional data","authors":"Rie Sakai-Bizmark, H. Kumamaru, Dennys Estevez, Sophia Neman, Lauren E. M. Bedel, Laurie A Mena, Emily H Marr, M. Ross","doi":"10.1136/bmjqs-2020-012898","DOIUrl":"https://doi.org/10.1136/bmjqs-2020-012898","url":null,"abstract":"Objective To assess differences in rates of postpartum hospitalisations among homeless women compared with non-homeless women. Design Cross-sectional secondary analysis of readmissions and emergency department (ED) utilisation among postpartum women using hierarchical regression models adjusted for age, race/ethnicity, insurance type during delivery, delivery length of stay, maternal comorbidity index score, other pregnancy complications, neonatal complications, caesarean delivery, year fixed effect and a birth hospital random effect. Setting New York statewide inpatient and emergency department databases (2009–2014). Participants 82 820 and 1 026 965 postpartum homeless and non-homeless women, respectively. Main outcome measures Postpartum readmissions (primary outcome) and postpartum ED visits (secondary outcome) within 6 weeks after discharge date from delivery hospitalisation. Results Homeless women had lower rates of both postpartum readmissions (risk-adjusted rates: 1.4% vs 1.6%; adjusted OR (aOR) 0.87, 95% CI 0.75 to 1.00, p=0.048) and ED visits than non-homeless women (risk-adjusted rates: 8.1% vs 9.5%; aOR 0.83, 95% CI 0.77 to 0.90, p<0.001). A sensitivity analysis stratifying the non-homeless population by income quartile revealed significantly lower hospitalisation rates of homeless women compared with housed women in the lowest income quartile. These results were surprising due to the trend of postpartum hospitalisation rates increasing as income levels decreased. Conclusions Two factors likely led to lower rates of hospital readmissions among homeless women. First, barriers including lack of transportation, payment or childcare could have impeded access to postpartum inpatient and emergency care. Second, given New York State’s extensive safety net, discharge planning such as respite and sober living housing may have provided access to outpatient care and quality of life, preventing adverse health events. Additional research using outpatient data and patient perspectives is needed to recognise how the factors affect postpartum health among homeless women. These findings could aid in lowering readmissions of the housed postpartum population.","PeriodicalId":49653,"journal":{"name":"Quality & Safety in Health Care","volume":"31 1","pages":"267 - 277"},"PeriodicalIF":0.0,"publicationDate":"2021-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41415561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
National cross-sectional cohort study of the relationship between quality of mental healthcare and death by suicide 精神卫生保健质量与自杀死亡关系的全国横断面队列研究
Pub Date : 2021-06-16 DOI: 10.1136/bmjqs-2020-012944
B. Shiner, D. Gottlieb, Maxwell Levis, Talya Peltzman, N. Riblet, Sarah L. Cornelius, Carey J Russ, B. Watts
Background Patient safety-based interventions aimed at lethal means restriction are effective at reducing death by suicide in inpatient mental health settings but are more challenging in the outpatient arena. As an alternative approach, we examined the association between quality of mental healthcare and suicide in a national healthcare system. Methods We calculated regional suicide rates for Department of Veterans Affairs (VA) Healthcare users from 2013 to 2017. To control for underlying variation in suicide risk in each of our 115 mental health referral regions (MHRRs), we calculated standardised rate ratios (SRRs) for VA users compared with the general population. We calculated quality metrics for outpatient mental healthcare in each MHRR using individual metrics as well as an Overall Quality Index. We assessed the correlation between quality metrics and suicide rates. Results Among the 115 VA MHRRs, the age-adjusted, sex-adjusted and race-adjusted annual suicide rates varied from 6.8 to 92.9 per 100 000 VA users, and the SRRs varied between 0.7 and 5.7. Mean regional-level adherence to each of our quality metrics ranged from a low of 7.7% for subspecialty care access to a high of 58.9% for care transitions. While there was substantial regional variation in quality, there was no correlation between an overall index of mental healthcare quality and SRR. Conclusion There was no correlation between overall quality of outpatient mental healthcare and rates of suicide in a national healthcare system. Although it is possible that quality was not high enough anywhere to prevent suicide at the population level or that we were unable to adequately measure quality, this examination of core mental health services in a well-resourced system raises doubts that a quality-based approach alone can lower population-level suicide rates.
背景:以患者安全为基础的干预措施旨在限制致命手段,在减少住院精神卫生机构的自杀死亡方面是有效的,但在门诊领域更具挑战性。作为一种替代方法,我们研究了国家卫生保健系统中精神卫生保健质量与自杀之间的关系。方法计算2013年至2017年退伍军人事务部(VA)医疗保健使用者的地区自杀率。为了控制115个心理健康转诊地区(MHRRs)中每个地区自杀风险的潜在差异,我们计算了VA使用者与普通人群的标准化比率(SRRs)。我们使用个体指标和总体质量指数计算了每个MHRR门诊精神卫生保健的质量指标。我们评估了质量指标与自杀率之间的相关性。结果115例退伍军人的mhrr中,年龄调整、性别调整和种族调整后的年自杀率为6.8 - 92.9 / 10万,srr为0.7 - 5.7 / 10万。每个质量指标的平均区域水平依从性范围从低至7.7%的亚专科护理获取到高至58.9%的护理转换。虽然在质量方面存在很大的区域差异,但精神卫生保健质量总体指数与SRR之间没有相关性。结论门诊精神卫生总体质量与自杀率之间不存在相关性。虽然有可能在任何地方的质量都不够高,无法在人口水平上预防自杀,或者我们无法充分衡量质量,但在资源充足的系统中对核心精神卫生服务的检查提出了质疑,即仅以质量为基础的方法就可以降低人口水平的自杀率。
{"title":"National cross-sectional cohort study of the relationship between quality of mental healthcare and death by suicide","authors":"B. Shiner, D. Gottlieb, Maxwell Levis, Talya Peltzman, N. Riblet, Sarah L. Cornelius, Carey J Russ, B. Watts","doi":"10.1136/bmjqs-2020-012944","DOIUrl":"https://doi.org/10.1136/bmjqs-2020-012944","url":null,"abstract":"Background Patient safety-based interventions aimed at lethal means restriction are effective at reducing death by suicide in inpatient mental health settings but are more challenging in the outpatient arena. As an alternative approach, we examined the association between quality of mental healthcare and suicide in a national healthcare system. Methods We calculated regional suicide rates for Department of Veterans Affairs (VA) Healthcare users from 2013 to 2017. To control for underlying variation in suicide risk in each of our 115 mental health referral regions (MHRRs), we calculated standardised rate ratios (SRRs) for VA users compared with the general population. We calculated quality metrics for outpatient mental healthcare in each MHRR using individual metrics as well as an Overall Quality Index. We assessed the correlation between quality metrics and suicide rates. Results Among the 115 VA MHRRs, the age-adjusted, sex-adjusted and race-adjusted annual suicide rates varied from 6.8 to 92.9 per 100 000 VA users, and the SRRs varied between 0.7 and 5.7. Mean regional-level adherence to each of our quality metrics ranged from a low of 7.7% for subspecialty care access to a high of 58.9% for care transitions. While there was substantial regional variation in quality, there was no correlation between an overall index of mental healthcare quality and SRR. Conclusion There was no correlation between overall quality of outpatient mental healthcare and rates of suicide in a national healthcare system. Although it is possible that quality was not high enough anywhere to prevent suicide at the population level or that we were unable to adequately measure quality, this examination of core mental health services in a well-resourced system raises doubts that a quality-based approach alone can lower population-level suicide rates.","PeriodicalId":49653,"journal":{"name":"Quality & Safety in Health Care","volume":"31 1","pages":"434 - 440"},"PeriodicalIF":0.0,"publicationDate":"2021-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47908432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care COVID-19限制对糖尿病健康检查和2型糖尿病患者处方的影响:一项全英国队列研究,涉及618161名初级保健人员
Pub Date : 2021-04-22 DOI: 10.1101/2021.04.21.21255869
M. Carr, A. Wright, L. Leelarathna, H. Thabit, N. Milne, N. Kanumilli, D. Ashcroft, M. Rutter
Objective To compare rates of performing National Institute for Health and Care Excellence-recommended health checks and prescribing in people with type 2 diabetes (T2D), before and after the first COVID-19 peak in March 2020, and to assess whether trends varied by age, sex, ethnicity and deprivation. Methods We studied 618 161 people with T2D followed between March and December 2020 from 1744 UK general practices registered with the Clinical Practice Research Datalink. We focused on six health checks: haemoglobin A1c, serum creatinine, cholesterol, urinary albumin excretion, blood pressure and body mass index assessment. Regression models compared observed rates in April 2020 and between March and December 2020 with trend-adjusted expected rates derived from 10-year historical data. Results In April 2020, in English practices, rates of performing health checks were reduced by 76%–88% when compared with 10-year historical trends, with older people from deprived areas experiencing the greatest reductions. Between May and December 2020, the reduced rates recovered gradually but overall remained 28%–47% lower, with similar findings in other UK nations. Extrapolated to the UK population, there were ~7.4 million fewer care processes undertaken March–December 2020. In England, rates for new medication fell during April with reductions varying from 10% (95% CI: 4% to 16%) for antiplatelet agents to 60% (95% CI: 58% to 62%) for antidiabetic medications. Overall, between March and December 2020, the rate of prescribing new diabetes medications fell by 19% (95% CI: 15% to 22%) and new antihypertensive medication prescribing fell by 22% (95% CI: 18% to 26%), but prescribing of new lipid-lowering or antiplatelet therapy was unchanged. Similar trends were observed across the UK, except for a reduction in new lipid-lowering therapy prescribing in the other UK nations (reduction: 16% (95% CI: 10% to 21%)). Extrapolated to the UK population, between March and December 2020, there were ~31 800 fewer people with T2D prescribed a new type of diabetes medication and ~14 600 fewer prescribed a new type of antihypertensive medication. Conclusions Over the coming months, healthcare services will need to manage this backlog of testing and prescribing. We recommend effective communications to ensure patient engagement with diabetes services, monitoring and opportunities for prescribing, and when appropriate use of home monitoring, remote consultations and other innovations in care.
目的比较2020年3月新冠肺炎首次高峰前后,2型糖尿病(T2D)患者执行国家卫生与护理卓越研究所推荐的健康检查和处方的比率,并评估趋势是否因年龄、性别、种族和剥夺而变化。方法我们研究了618 2020年3月至12月,从1744家在临床实践研究数据链接注册的英国全科诊所中,161名T2D患者接受了随访。我们重点进行了六项健康检查:血红蛋白A1c、血清肌酐、胆固醇、尿白蛋白排泄、血压和体重指数评估。回归模型将2020年4月和2020年3月至12月的观察到的利率与根据10年历史数据得出的趋势调整后的预期利率进行了比较。结果2020年4月,在英国诊所,进行健康检查的比率下降了76%-88% 与10年的历史趋势相比,贫困地区的老年人减少幅度最大。在2020年5月至12月期间,降低的利率逐渐恢复,但总体保持在28%-47% 更低,其他英国国家也有类似的发现。根据英国人口推断,2020年3月至12月的护理流程减少了约740万次。在英格兰,4月份新药的使用率下降,从抗血小板药物的10%(95%CI:4%-16%)到抗糖尿病药物的60%(95%CI:58%-62%)不等。总体而言,在2020年3月至12月期间,糖尿病新药的处方率下降了19%(95%置信区间:15%至22%),抗高血压新药的处方下降了22%(95%可信区间:18%至26%),但新的降脂或抗血小板疗法的处方没有变化。在英国各地也观察到了类似的趋势,除了英国其他国家新的降脂治疗处方减少(减少:16%(95%置信区间:10%至21%))。根据英国人口推断,在2020年3月至12月期间,约有31人 T2D患者开新型糖尿病药物的人数减少了800人,约14人 开了一种新型降压药的人减少了600人。结论在未来几个月,医疗服务部门将需要管理积压的检测和处方。我们建议进行有效的沟通,以确保患者参与糖尿病服务、监测和开处方的机会,并在适当的时候使用家庭监测、远程咨询和其他护理创新。
{"title":"Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care","authors":"M. Carr, A. Wright, L. Leelarathna, H. Thabit, N. Milne, N. Kanumilli, D. Ashcroft, M. Rutter","doi":"10.1101/2021.04.21.21255869","DOIUrl":"https://doi.org/10.1101/2021.04.21.21255869","url":null,"abstract":"Objective To compare rates of performing National Institute for Health and Care Excellence-recommended health checks and prescribing in people with type 2 diabetes (T2D), before and after the first COVID-19 peak in March 2020, and to assess whether trends varied by age, sex, ethnicity and deprivation. Methods We studied 618 161 people with T2D followed between March and December 2020 from 1744 UK general practices registered with the Clinical Practice Research Datalink. We focused on six health checks: haemoglobin A1c, serum creatinine, cholesterol, urinary albumin excretion, blood pressure and body mass index assessment. Regression models compared observed rates in April 2020 and between March and December 2020 with trend-adjusted expected rates derived from 10-year historical data. Results In April 2020, in English practices, rates of performing health checks were reduced by 76%–88% when compared with 10-year historical trends, with older people from deprived areas experiencing the greatest reductions. Between May and December 2020, the reduced rates recovered gradually but overall remained 28%–47% lower, with similar findings in other UK nations. Extrapolated to the UK population, there were ~7.4 million fewer care processes undertaken March–December 2020. In England, rates for new medication fell during April with reductions varying from 10% (95% CI: 4% to 16%) for antiplatelet agents to 60% (95% CI: 58% to 62%) for antidiabetic medications. Overall, between March and December 2020, the rate of prescribing new diabetes medications fell by 19% (95% CI: 15% to 22%) and new antihypertensive medication prescribing fell by 22% (95% CI: 18% to 26%), but prescribing of new lipid-lowering or antiplatelet therapy was unchanged. Similar trends were observed across the UK, except for a reduction in new lipid-lowering therapy prescribing in the other UK nations (reduction: 16% (95% CI: 10% to 21%)). Extrapolated to the UK population, between March and December 2020, there were ~31 800 fewer people with T2D prescribed a new type of diabetes medication and ~14 600 fewer prescribed a new type of antihypertensive medication. Conclusions Over the coming months, healthcare services will need to manage this backlog of testing and prescribing. We recommend effective communications to ensure patient engagement with diabetes services, monitoring and opportunities for prescribing, and when appropriate use of home monitoring, remote consultations and other innovations in care.","PeriodicalId":49653,"journal":{"name":"Quality & Safety in Health Care","volume":"31 1","pages":"503 - 514"},"PeriodicalIF":0.0,"publicationDate":"2021-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46257889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 45
期刊
Quality & Safety in Health Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1